STOCK TITAN

Genius Sports CEO Mark Locke discloses 7.2% stake via 13G/A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Genius Sports (GENI): Mark Locke filed Amendment No. 4 to Schedule 13G reporting beneficial ownership of 17,070,924 ordinary shares, representing 7.2% of the class. The filing lists sole voting and sole dispositive power over the same 17,070,924 shares and no shared powers.

The percentage is calculated based on 238,718,120 shares outstanding as of September 30, 2025, as referenced from an Exhibit to a Form 6-K. The date of event requiring the filing is September 30, 2025. The reporting person is Mark Locke, Chief Executive Officer of Genius Sports Limited.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: (1) Represents 17,070,924 ordinary shares. (2) Calculated based on 238,718,120 shares outstanding as of September 30, 2025, as reported on Exhibit 99.1 to the Issuer's Report on Form 6-K, furnished to the United States Securities and Exchange Commission on November 4, 2025.


SCHEDULE 13G



Mark Locke
Signature:/s/ Mark Locke
Name/Title:Mark Locke, Chief Executive Officer
Date:11/14/2025

FAQ

What did GENI disclose in this Schedule 13G/A?

Mark Locke reported beneficial ownership of 17,070,924 ordinary shares, or 7.2% of Genius Sports’ outstanding shares.

Who is the reporting person in GENI’s 13G/A?

The filing is by Mark Locke, Chief Executive Officer of Genius Sports Limited.

What is the basis for the 7.2% ownership figure for GENI?

It is calculated using 238,718,120 shares outstanding as of September 30, 2025, cited from an Exhibit to a Form 6-K.

What voting and dispositive powers does Mark Locke report for GENI?

He reports sole voting power and sole dispositive power over 17,070,924 shares, with no shared powers.

What is the event date tied to this GENI ownership report?

The date of event requiring the filing is September 30, 2025.

What class of securities is covered in GENI’s 13G/A?

Ordinary Shares, par value $0.01 per share (CUSIP G3934V109).

Is this a new filing or an amendment for GENI?

It is Amendment No. 4 to Schedule 13G.
Genius Sports Limited

NYSE:GENI

GENI Rankings

GENI Latest News

GENI Latest SEC Filings

GENI Stock Data

1.52B
218.02M
Internet Content & Information
Communication Services
Link
United Kingdom
London